Table 6 Top 10 articles with the highest number of co-citations
From: Bibliometric analysis of residual cardiovascular risk: trends and frontiers
Rank | Title | Journal | Author | Year | LC |
|---|---|---|---|---|---|
1 | Effects of combination lipid therapy in type 2 diabetes mellitus | New Engl J Med | Ginsberg HN | 2010 | 177 |
2 | Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials | Lancet | Baigent C | 2010 | 174 |
3 | Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins | Lancet | Baigent C | 2005 | 170 |
4 | Effects of torcetrapib in patients at high risk for coronary events | New Engl J Med | Barter PJ | 2007 | 157 |
5 | Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy | New Engl J Med | Boden WE | 2011 | 153 |
6 | Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial | Lancet | Keech A | 2005 | 138 |
7 | Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease | New Engl J Med | Sabatine MS | 2017 | 135 |
8 | Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes | New Engl J Med | Cannon CP | 2015 | 131 |
9 | Intensive versus moderate lipid lowering with statins after acute coronary syndromes | New Engl J Med | Cannon CP | 2004 | 124 |
10 | Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | New Engl J Med | Ridker PM | 2008 | 120 |